Degradation-resistant trehalose analogues block utilization of trehalose by hypervirulent Clostridioides difficile

Trehalose is used as an additive in thousands of foods, cosmetics, and pharmaceutical products, and it is being investigated as a therapeutic for multiple human diseases. However, its ability to be used as a carbon source by microbes is a concern, as highlighted by the recent finding that trehalose...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chemical communications (Cambridge, England) England), 2019-04, Vol.55 (34), p.5009-5012
Hauptverfasser: Danielson, Noah D, Collins, James, Stothard, Alicyn I, Dong, Qing Qing, Kalera, Karishma, Woodruff, Peter J, DeBosch, Brian J, Britton, Robert A, Swarts, Benjamin M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 5012
container_issue 34
container_start_page 5009
container_title Chemical communications (Cambridge, England)
container_volume 55
creator Danielson, Noah D
Collins, James
Stothard, Alicyn I
Dong, Qing Qing
Kalera, Karishma
Woodruff, Peter J
DeBosch, Brian J
Britton, Robert A
Swarts, Benjamin M
description Trehalose is used as an additive in thousands of foods, cosmetics, and pharmaceutical products, and it is being investigated as a therapeutic for multiple human diseases. However, its ability to be used as a carbon source by microbes is a concern, as highlighted by the recent finding that trehalose can be metabolized by and potentially enhance the virulence of epidemic Clostridioides difficile. Here, we show that trehalose analogues designed to resist enzymatic degradation are incapable of being used as carbon sources by C. difficile. Furthermore, we demonstrate that trehalose analogues, but not the known trehalase inhibitor validamycin A, inhibit native trehalose utilization by hypervirulent C. difficile. Thus, degradation-resistant trehalose analogues are valuable as trehalase inhibitors and as surrogates for or co-additives with trehalose in applications where enzymatic breakdown is a concern.
doi_str_mv 10.1039/c9cc01300h
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6499371</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2237544930</sourcerecordid><originalsourceid>FETCH-LOGICAL-c439t-b0fece585e73e103790e22df37913858490ca4e06b77460375cffc6ddd342e483</originalsourceid><addsrcrecordid>eNqNkU1v3CAQhlHVqvloL_kBkaVeqkhuwIAxl0qRmy8pUi6p1BvCMOySsmYLdqTNry-bpFHSU7jMiHl4mZkXoQOCvxFM5bGRxmBCMV6-Q7uEtqzmrPv1fptzWQvK-A7ay_kWl0N49xHtUCzbrpNkF6UfsEja6snHsU6QfZ70OFVTgqUOMUOlxxIXM-RqCNH8rubJB3__wFfRvQCHTbXcrCHd-TQHKBp9uZ6Stz56W55b75w3PsAn9MHpkOHzU9xHP89Ob_qL-ur6_LI_uaoNo3KqB-zAAO84CAplTiExNI11JSG04x2T2GgGuB2EYG2pc-Ocaa21lDXAOrqPvj_qrudhBdaUnpIOap38SqeNitqr15XRL9Ui3qmWSUkFKQJfnwRS_FM2MKmVzwZC0CPEOaumKZ8yJil-A4oFaQkRW_TLf-htnFPZ8pYijcCSNbxQR4-USTHnBO65b4LV1nXVy75_cP2iwIcvJ31G_9lM_wL0pKqc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2212709425</pqid></control><display><type>article</type><title>Degradation-resistant trehalose analogues block utilization of trehalose by hypervirulent Clostridioides difficile</title><source>MEDLINE</source><source>Royal Society Of Chemistry Journals 2008-</source><source>Alma/SFX Local Collection</source><creator>Danielson, Noah D ; Collins, James ; Stothard, Alicyn I ; Dong, Qing Qing ; Kalera, Karishma ; Woodruff, Peter J ; DeBosch, Brian J ; Britton, Robert A ; Swarts, Benjamin M</creator><creatorcontrib>Danielson, Noah D ; Collins, James ; Stothard, Alicyn I ; Dong, Qing Qing ; Kalera, Karishma ; Woodruff, Peter J ; DeBosch, Brian J ; Britton, Robert A ; Swarts, Benjamin M</creatorcontrib><description>Trehalose is used as an additive in thousands of foods, cosmetics, and pharmaceutical products, and it is being investigated as a therapeutic for multiple human diseases. However, its ability to be used as a carbon source by microbes is a concern, as highlighted by the recent finding that trehalose can be metabolized by and potentially enhance the virulence of epidemic Clostridioides difficile. Here, we show that trehalose analogues designed to resist enzymatic degradation are incapable of being used as carbon sources by C. difficile. Furthermore, we demonstrate that trehalose analogues, but not the known trehalase inhibitor validamycin A, inhibit native trehalose utilization by hypervirulent C. difficile. Thus, degradation-resistant trehalose analogues are valuable as trehalase inhibitors and as surrogates for or co-additives with trehalose in applications where enzymatic breakdown is a concern.</description><identifier>ISSN: 1359-7345</identifier><identifier>ISSN: 1364-548X</identifier><identifier>EISSN: 1364-548X</identifier><identifier>DOI: 10.1039/c9cc01300h</identifier><identifier>PMID: 30968891</identifier><language>eng</language><publisher>England: Royal Society of Chemistry</publisher><subject>Additives ; Animals ; Carbohydrate Conformation ; Carbon ; chemical compounds ; chemical reactions ; Clostridioides difficile - drug effects ; Clostridioides difficile - metabolism ; Clostridium difficile ; Cosmetics ; Degradation ; Dose-Response Relationship, Drug ; drugs ; enzyme inhibitors ; Epidemics ; foods ; human diseases ; Human performance ; microorganisms ; Swine ; therapeutics ; trehalase ; Trehalase - antagonists &amp; inhibitors ; Trehalase - metabolism ; Trehalose ; Trehalose - chemistry ; Trehalose - metabolism ; Trehalose - pharmacology ; Virulence</subject><ispartof>Chemical communications (Cambridge, England), 2019-04, Vol.55 (34), p.5009-5012</ispartof><rights>Copyright Royal Society of Chemistry 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c439t-b0fece585e73e103790e22df37913858490ca4e06b77460375cffc6ddd342e483</citedby><cites>FETCH-LOGICAL-c439t-b0fece585e73e103790e22df37913858490ca4e06b77460375cffc6ddd342e483</cites><orcidid>0000-0003-2479-5189 ; 0000-0001-8402-359X ; 0000-0002-9924-7921 ; 0000-0001-8983-9539</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30968891$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Danielson, Noah D</creatorcontrib><creatorcontrib>Collins, James</creatorcontrib><creatorcontrib>Stothard, Alicyn I</creatorcontrib><creatorcontrib>Dong, Qing Qing</creatorcontrib><creatorcontrib>Kalera, Karishma</creatorcontrib><creatorcontrib>Woodruff, Peter J</creatorcontrib><creatorcontrib>DeBosch, Brian J</creatorcontrib><creatorcontrib>Britton, Robert A</creatorcontrib><creatorcontrib>Swarts, Benjamin M</creatorcontrib><title>Degradation-resistant trehalose analogues block utilization of trehalose by hypervirulent Clostridioides difficile</title><title>Chemical communications (Cambridge, England)</title><addtitle>Chem Commun (Camb)</addtitle><description>Trehalose is used as an additive in thousands of foods, cosmetics, and pharmaceutical products, and it is being investigated as a therapeutic for multiple human diseases. However, its ability to be used as a carbon source by microbes is a concern, as highlighted by the recent finding that trehalose can be metabolized by and potentially enhance the virulence of epidemic Clostridioides difficile. Here, we show that trehalose analogues designed to resist enzymatic degradation are incapable of being used as carbon sources by C. difficile. Furthermore, we demonstrate that trehalose analogues, but not the known trehalase inhibitor validamycin A, inhibit native trehalose utilization by hypervirulent C. difficile. Thus, degradation-resistant trehalose analogues are valuable as trehalase inhibitors and as surrogates for or co-additives with trehalose in applications where enzymatic breakdown is a concern.</description><subject>Additives</subject><subject>Animals</subject><subject>Carbohydrate Conformation</subject><subject>Carbon</subject><subject>chemical compounds</subject><subject>chemical reactions</subject><subject>Clostridioides difficile - drug effects</subject><subject>Clostridioides difficile - metabolism</subject><subject>Clostridium difficile</subject><subject>Cosmetics</subject><subject>Degradation</subject><subject>Dose-Response Relationship, Drug</subject><subject>drugs</subject><subject>enzyme inhibitors</subject><subject>Epidemics</subject><subject>foods</subject><subject>human diseases</subject><subject>Human performance</subject><subject>microorganisms</subject><subject>Swine</subject><subject>therapeutics</subject><subject>trehalase</subject><subject>Trehalase - antagonists &amp; inhibitors</subject><subject>Trehalase - metabolism</subject><subject>Trehalose</subject><subject>Trehalose - chemistry</subject><subject>Trehalose - metabolism</subject><subject>Trehalose - pharmacology</subject><subject>Virulence</subject><issn>1359-7345</issn><issn>1364-548X</issn><issn>1364-548X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU1v3CAQhlHVqvloL_kBkaVeqkhuwIAxl0qRmy8pUi6p1BvCMOySsmYLdqTNry-bpFHSU7jMiHl4mZkXoQOCvxFM5bGRxmBCMV6-Q7uEtqzmrPv1fptzWQvK-A7ay_kWl0N49xHtUCzbrpNkF6UfsEja6snHsU6QfZ70OFVTgqUOMUOlxxIXM-RqCNH8rubJB3__wFfRvQCHTbXcrCHd-TQHKBp9uZ6Stz56W55b75w3PsAn9MHpkOHzU9xHP89Ob_qL-ur6_LI_uaoNo3KqB-zAAO84CAplTiExNI11JSG04x2T2GgGuB2EYG2pc-Ocaa21lDXAOrqPvj_qrudhBdaUnpIOap38SqeNitqr15XRL9Ui3qmWSUkFKQJfnwRS_FM2MKmVzwZC0CPEOaumKZ8yJil-A4oFaQkRW_TLf-htnFPZ8pYijcCSNbxQR4-USTHnBO65b4LV1nXVy75_cP2iwIcvJ31G_9lM_wL0pKqc</recordid><startdate>20190423</startdate><enddate>20190423</enddate><creator>Danielson, Noah D</creator><creator>Collins, James</creator><creator>Stothard, Alicyn I</creator><creator>Dong, Qing Qing</creator><creator>Kalera, Karishma</creator><creator>Woodruff, Peter J</creator><creator>DeBosch, Brian J</creator><creator>Britton, Robert A</creator><creator>Swarts, Benjamin M</creator><general>Royal Society of Chemistry</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SR</scope><scope>7U5</scope><scope>8BQ</scope><scope>8FD</scope><scope>JG9</scope><scope>L7M</scope><scope>7X8</scope><scope>7S9</scope><scope>L.6</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-2479-5189</orcidid><orcidid>https://orcid.org/0000-0001-8402-359X</orcidid><orcidid>https://orcid.org/0000-0002-9924-7921</orcidid><orcidid>https://orcid.org/0000-0001-8983-9539</orcidid></search><sort><creationdate>20190423</creationdate><title>Degradation-resistant trehalose analogues block utilization of trehalose by hypervirulent Clostridioides difficile</title><author>Danielson, Noah D ; Collins, James ; Stothard, Alicyn I ; Dong, Qing Qing ; Kalera, Karishma ; Woodruff, Peter J ; DeBosch, Brian J ; Britton, Robert A ; Swarts, Benjamin M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c439t-b0fece585e73e103790e22df37913858490ca4e06b77460375cffc6ddd342e483</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Additives</topic><topic>Animals</topic><topic>Carbohydrate Conformation</topic><topic>Carbon</topic><topic>chemical compounds</topic><topic>chemical reactions</topic><topic>Clostridioides difficile - drug effects</topic><topic>Clostridioides difficile - metabolism</topic><topic>Clostridium difficile</topic><topic>Cosmetics</topic><topic>Degradation</topic><topic>Dose-Response Relationship, Drug</topic><topic>drugs</topic><topic>enzyme inhibitors</topic><topic>Epidemics</topic><topic>foods</topic><topic>human diseases</topic><topic>Human performance</topic><topic>microorganisms</topic><topic>Swine</topic><topic>therapeutics</topic><topic>trehalase</topic><topic>Trehalase - antagonists &amp; inhibitors</topic><topic>Trehalase - metabolism</topic><topic>Trehalose</topic><topic>Trehalose - chemistry</topic><topic>Trehalose - metabolism</topic><topic>Trehalose - pharmacology</topic><topic>Virulence</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Danielson, Noah D</creatorcontrib><creatorcontrib>Collins, James</creatorcontrib><creatorcontrib>Stothard, Alicyn I</creatorcontrib><creatorcontrib>Dong, Qing Qing</creatorcontrib><creatorcontrib>Kalera, Karishma</creatorcontrib><creatorcontrib>Woodruff, Peter J</creatorcontrib><creatorcontrib>DeBosch, Brian J</creatorcontrib><creatorcontrib>Britton, Robert A</creatorcontrib><creatorcontrib>Swarts, Benjamin M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Engineered Materials Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>MEDLINE - Academic</collection><collection>AGRICOLA</collection><collection>AGRICOLA - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Chemical communications (Cambridge, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Danielson, Noah D</au><au>Collins, James</au><au>Stothard, Alicyn I</au><au>Dong, Qing Qing</au><au>Kalera, Karishma</au><au>Woodruff, Peter J</au><au>DeBosch, Brian J</au><au>Britton, Robert A</au><au>Swarts, Benjamin M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Degradation-resistant trehalose analogues block utilization of trehalose by hypervirulent Clostridioides difficile</atitle><jtitle>Chemical communications (Cambridge, England)</jtitle><addtitle>Chem Commun (Camb)</addtitle><date>2019-04-23</date><risdate>2019</risdate><volume>55</volume><issue>34</issue><spage>5009</spage><epage>5012</epage><pages>5009-5012</pages><issn>1359-7345</issn><issn>1364-548X</issn><eissn>1364-548X</eissn><abstract>Trehalose is used as an additive in thousands of foods, cosmetics, and pharmaceutical products, and it is being investigated as a therapeutic for multiple human diseases. However, its ability to be used as a carbon source by microbes is a concern, as highlighted by the recent finding that trehalose can be metabolized by and potentially enhance the virulence of epidemic Clostridioides difficile. Here, we show that trehalose analogues designed to resist enzymatic degradation are incapable of being used as carbon sources by C. difficile. Furthermore, we demonstrate that trehalose analogues, but not the known trehalase inhibitor validamycin A, inhibit native trehalose utilization by hypervirulent C. difficile. Thus, degradation-resistant trehalose analogues are valuable as trehalase inhibitors and as surrogates for or co-additives with trehalose in applications where enzymatic breakdown is a concern.</abstract><cop>England</cop><pub>Royal Society of Chemistry</pub><pmid>30968891</pmid><doi>10.1039/c9cc01300h</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0003-2479-5189</orcidid><orcidid>https://orcid.org/0000-0001-8402-359X</orcidid><orcidid>https://orcid.org/0000-0002-9924-7921</orcidid><orcidid>https://orcid.org/0000-0001-8983-9539</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1359-7345
ispartof Chemical communications (Cambridge, England), 2019-04, Vol.55 (34), p.5009-5012
issn 1359-7345
1364-548X
1364-548X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6499371
source MEDLINE; Royal Society Of Chemistry Journals 2008-; Alma/SFX Local Collection
subjects Additives
Animals
Carbohydrate Conformation
Carbon
chemical compounds
chemical reactions
Clostridioides difficile - drug effects
Clostridioides difficile - metabolism
Clostridium difficile
Cosmetics
Degradation
Dose-Response Relationship, Drug
drugs
enzyme inhibitors
Epidemics
foods
human diseases
Human performance
microorganisms
Swine
therapeutics
trehalase
Trehalase - antagonists & inhibitors
Trehalase - metabolism
Trehalose
Trehalose - chemistry
Trehalose - metabolism
Trehalose - pharmacology
Virulence
title Degradation-resistant trehalose analogues block utilization of trehalose by hypervirulent Clostridioides difficile
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T21%3A44%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Degradation-resistant%20trehalose%20analogues%20block%20utilization%20of%20trehalose%20by%20hypervirulent%20Clostridioides%20difficile&rft.jtitle=Chemical%20communications%20(Cambridge,%20England)&rft.au=Danielson,%20Noah%20D&rft.date=2019-04-23&rft.volume=55&rft.issue=34&rft.spage=5009&rft.epage=5012&rft.pages=5009-5012&rft.issn=1359-7345&rft.eissn=1364-548X&rft_id=info:doi/10.1039/c9cc01300h&rft_dat=%3Cproquest_pubme%3E2237544930%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2212709425&rft_id=info:pmid/30968891&rfr_iscdi=true